These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16877809)

  • 1. Application of multiplex FISH, CGH and MSSCP techniques for cytogenetic and molecular analysis of transitional cell carcinoma (TCC) cells in voided urine specimens.
    Constantinou M; Binka-Kowalska A; Borkowska E; Zajac E; Jałmuzna P; Matych J; Nawrocka A; Kałuzewski B
    J Appl Genet; 2006; 47(3):273-5. PubMed ID: 16877809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cytogenetic characterization and diagnostics of bladder cancer.
    Houskova L; Zemanova Z; Babjuk M; Melichercikova J; Pesl M; Michalova K
    Neoplasma; 2007; 54(6):511-6. PubMed ID: 17949235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization.
    Voorter C; Joos S; Bringuier PP; Vallinga M; Poddighe P; Schalken J; du Manoir S; Ramaekers F; Lichter P; Hopman A
    Am J Pathol; 1995 Jun; 146(6):1341-54. PubMed ID: 7778674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Numerical aberrations of chromosomes 7, 9 and 17 in squamous cell and transitional cell cancer of the bladder: a comparative study performed by fluorescence in situ hybridization.
    Pycha A; Mian C; Posch B; Haitel A; El-Baz M; Ghoneim MA; Marberger M
    J Urol; 1998 Sep; 160(3 Pt 1):737-40. PubMed ID: 9720535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cytogenetic analysis of urothelial carcinomas using urine samples.
    Ayati M; Tousi VN; Sabokba T; Vaziri-Nasab H; Mehrkhani F; Jamshidian H; Dastan J; Mosavi-Jarrahi AR; Ghaffari SR
    Asian Pac J Cancer Prev; 2008; 9(4):687-90. PubMed ID: 19256760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of specific chromosomal aberrations in urine using BCA-1 (oligo-CGH-array) enhances diagnostic sensitivity and predicts the aggressiveness of non-muscle-invasive bladder transitional cell carcinoma.
    Cussenot O; Sighar K; Mohammed M; Hugonin S; Ondet V; Larre S; Lacave R; Roupret M; Cancel-Tassin G
    World J Urol; 2014 Apr; 32(2):551-7. PubMed ID: 24196429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
    Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
    J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma.
    Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA
    Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence in situ hybridization assay detects upper urinary tract transitional cell carcinoma in patients with asymptomatic hematuria and negative urine cytology.
    Huang WT; Li LY; Pang J; Ruan XX; Sun QP; Yang WJ; Gao X
    Neoplasma; 2012; 59(4):355-60. PubMed ID: 22489689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 gene mutation in recurrent superficial bladder cancer.
    Yoshimura I; Kudoh J; Saito S; Tazaki H; Shimizu N
    J Urol; 1995 May; 153(5):1711-5. PubMed ID: 7715016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of loss of heterozygosity in the p53 tumor-suppressor gene with PCR in the urine of patients with bladder cancer.
    Friedrich MG; Erbersdobler A; Schwaibold H; Conrad S; Huland E; Huland H
    J Urol; 2000 Mar; 163(3):1039-42. PubMed ID: 10688045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer.
    Simon R; Bürger H; Brinkschmidt C; Böcker W; Hertle L; Terpe HJ
    J Pathol; 1998 Aug; 185(4):345-51. PubMed ID: 9828832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P53 mutations in urinary bladder cancer patients from Central Poland.
    Borkowska E; Binka-Kowalska A; Constantinou M; Nawrocka A; Matych J; Kałuzewski B
    J Appl Genet; 2007; 48(2):177-83. PubMed ID: 17495352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic loss on chromosome 9 in bladder cancer tissues and urine samples detected by blunt-end single-strand DNA conformation polymorphism.
    Shigyo M; Sugano K; Fukayama N; Taniguchi T; Tobisu K; Fujimoto H; Doi N; Niwakawa M; Shimamura K; Tsukamoto T; Sekiya T; Kakizoe T
    Int J Cancer; 1998 Nov; 78(4):425-9. PubMed ID: 9797129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal imbalances in small cell carcinomas of the urinary bladder.
    Terracciano L; Richter J; Tornillo L; Beffa L; Diener PA; Maurer R; Gasser TC; Moch H; Mihatsch MJ; Sauter G
    J Pathol; 1999 Oct; 189(2):230-5. PubMed ID: 10547580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of chromosomal imbalances in muscle invasive bladder cancer.
    Simon R; Burger H; Semjonow A; Hertle L; Terpe HJ; Bocker W
    Int J Oncol; 2000 Nov; 17(5):1025-9. PubMed ID: 11029508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent association of p53 gene mutation in invasive bladder cancer.
    Fujimoto K; Yamada Y; Okajima E; Kakizoe T; Sasaki H; Sugimura T; Terada M
    Cancer Res; 1992 Mar; 52(6):1393-8. PubMed ID: 1540947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal imbalances in successive moments of human bladder urothelial carcinoma.
    Nascimento e Pontes MG; da Silveira SM; Trindade Filho JC; Rogatto SR; Viana de Camargo JL
    Urol Oncol; 2013 Aug; 31(6):827-35. PubMed ID: 21763161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular cytogenetic study of bladder transitional cell carcinoma by FISH].
    Shou J; Wang M; Ma J
    Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):36-8. PubMed ID: 11776593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.